Metabolic research
GLP-3 (RT) Pen – 40 mg
40 mg triple-agonist research pen
GLP-3 (RT) Pen – 40 mg is researched in research peptide comparison, with literature context focused on mechanism, pathway role, and evidence maturity.
This product has an available COA with reported batch details and test results.
Open available COAConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesPour la recherche en laboratoire uniquement. Pas pour un usage humain ou vétérinaire. Non destiné à diagnostiquer, traiter, guérir, atténuer ou prévenir une maladie.
Conserver scellé, froid, sec et protégé des variations de chaleur. Confirmez le stockage spécifique au produit à l'arrivée.
Emballé pour la stabilité du transit avec une assistance aux commandes disponible pour les itinéraires par temps chaud.
Batch-linked certificate support is available through the documentation desk.
Contexte de recherche
Profil de recherche GLP-3 (RT) Pen – 40 mg
GLP-3 (RT) Pen – 40 mg is supplied for controlled laboratory research. Material-specific context and available support are presented separately from external literature. External publications describe their own study materials and methods and do not independently establish the identity, performance, safety, or suitability of this catalog item.
Molecular class
39-residue acylated multi-receptor agonist
Sequence / composition
A 39-amino-acid engineered backbone with non-native substitutions and a C20 fatty-diacid side chain.
Research design note
The lipid side chain is used in pharmacology research to prolong exposure; receptor activity is studied across GIPR, GLP-1R, and GCGR.
Mécanisme proposé
A compound-specific proposed mechanism has not yet been added for GLP-3 (RT) Pen – 40 mg. Confirm molecular identity before assigning a receptor or pathway.
Effets rapportés dans les études
- No compound-specific experimental effects are listed until the molecular identity and literature record are confirmed.
Critères de recherche courants
Identity, purity, amount, stability, pathway activity, model-specific endpoints, and appropriate controls.
Preuves et limites
External literature must be matched to the exact material and study model before conclusions are drawn.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.